Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

219.72
-11.4600-4.96%
Post-market: 219.70-0.0200-0.01%19:49 EDT
Volume:1.66M
Turnover:369.84M
Market Cap:29.32B
PE:39.10
High:231.36
Open:231.31
Low:219.40
Close:231.18
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.37
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:21.65
PE(LYR):94.30

Loading ...

Alnylam to host 10th RNAi Roundtable webcast series on pipeline updates

Reuters
·
Jun 12

Alnylam, Genesis Pharma Expand Commercial Partnership Into 4 Nordic Markets

MT Newswires Live
·
Jun 10

Genesis Pharma: Extended Agreement With Alnylam Pharmaceuticals NOW Includes Denmark, Finland, Norway, and Sweden

THOMSON REUTERS
·
Jun 10

Genesis Pharma Expands Strategic Commercial Partnership With Alnylam Pharmaceuticals for Rnai Therapeutics to Nordic Region

THOMSON REUTERS
·
Jun 10

Alnylam expands GENESIS Pharma commercialization partnership to Nordic markets

Reuters
·
Jun 10

Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500

Dow Jones
·
Jun 09

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-08

Reuters
·
Jun 08

Alnylam Pharmaceuticals Price Target Maintained With a $510.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)

TIPRANKS
·
Jun 05

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-04

Reuters
·
Jun 04

Alnylam And Inceptive Form Strategic AI Collaboration To Accelerate Discovery Of RNAi Therapeutics

Reuters
·
Jun 04

Alnylam Commits Up to $2B to AI-Driven Therapeutic Innovation -- Company Talk

Dow Jones
·
Jun 04

Alnylam Collaboration Aims to Accelerate Timelines For Drug Discovery -- Company Talk

Dow Jones
·
Jun 04

Alnylam, Inceptive form strategic AI collaboration

TIPRANKS
·
Jun 04

Alnylam partners with Inceptive in AI-driven RNAi drug discovery deal worth up to $2 billion

Reuters
·
Jun 04

Alnylam Pharmaceuticals - Co and Inceptive Collaboration Valued at up to $2 Bln With $30 Mln Upfront

THOMSON REUTERS
·
Jun 04

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of Rnai Therapeutics

THOMSON REUTERS
·
Jun 04

Alnylam director David E.I. Pyott disposes of USD 1.14 million in common shares

Reuters
·
Jun 04

Alnylam files Form 3 for director Benjamin Cravatt

Reuters
·
Jun 04

How Investors May Respond To Alnylam Pharmaceuticals (ALNY) Adding Scientific Depth Amid RNAi Pipeline Scrutiny

Simply Wall St.
·
May 29